Search results

1. ESMO 2024 preview – TIGIT gets its late-breaker

   ESMO 2024 preview – TIGIT gets its late-breaker … the discontinuation of LOXO-783 .   Selected ESMO 2024 late-breakers* Project Company …

   
    

   Jacob Plieth
    
   - 09/09/2024 - 14:48

2. ESMO 2024 preview – presidential focus

   ESMO 2024 preview – presidential focus … settings’ respective effects.   Selected ESMO 2024 presidential presentations Project …

   
    

   Jacob Plieth
    
   - 08/27/2024 - 16:15

3. Opdualag sets its sights on lung

   … NSCLC Ph2 chemo combo, vs Opdivo + chemo, data at ESMO 2024 Relativity-069 2nd-line Hodgkin’s …

   
    

   Jacob Plieth
    
   - 02/14/2025 - 11:24

4. Is this the end for MacroGenics’ vobra-duo?

   … Ph2 Tamarack trial discontinued Jul 2024; more data due at ESMO 2024 Lorigerlimab Anti-PD-1 x CTLA-4 …

   
    

   Madeleine Armstrong
    
   - 08/05/2024 - 12:30

5. ESMO 2024 preview – Summit and BioNTech battle again

   ESMO 2024 preview – Summit and BioNTech battle again … NGM707 (which also hits ILT4).   Selected ESMO 2024 oral presentations featuring biologicals …

   
    

   Madeleine Armstrong
    
   - 07/24/2024 - 10:26

6. ESMO 2024 preview – Astellas unveils its KRAS degrader

   ESMO 2024 preview – Astellas unveils its KRAS degrader … straight SMARCA2 inhibitor FHD-909 .   Selected ESMO 2024 oral presentations on small-molecule approaches …

   
    

   Jacob Plieth
    
   - 07/24/2024 - 17:44

7. ESMO 2024 preview – conjugates in the spotlight

   ESMO 2024 preview – conjugates in the spotlight … hasn't yet yielded any clinical data.   Selected ESMO 2024 oral presentations featuring ADCs …

   
    

   Jacob Plieth
    
   - 07/23/2024 - 13:17